Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

CHRS

Coherus Oncology, Inc.

CIK 0001512762 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$1.42
↑ 0.10 (7.58%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals

Key stats

Market Cap
$219.39M
P/E Ratio
-1.66
EPS
1.43
Dividend Yield
Not covered
52W Position
23%
Beta
1.99

Valuation multiples

Fwd P/E
41.15
PEG
0.00
P/B
3.61
P/S
4.31
EV/Revenue
2.68
ROE
-217.2%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 23%
$1.06$2.62

Latest Financials

2025-12-31 FY
Revenue
$42.17M
Net Income
$168.02M
Total Assets
$258.34M
Free Cash Flow
–

Recent news